Institute for Myeloma & Bone Cancer Research

05/24/2026

Your dedicated scientists from IMBCR wish you and yours a Happy Memorial Day!
"Clinical Pearls" by Dr. James R. Berenson

A 90 year-old white female with Waldenstrom’s macroglobulinemia who has been on Velcade and steroid maintenance therapy for 5 years after responding to initial treatment with Doxil, Velcade, and dexamethasone induction therapy.

05/22/2026

Clinical Pearls from May 19, 2026, James R. Berenson, MD
BerensonCancerCenter.com
A 49 year-old white female with a history of smoldering myeloma with rising IgG, M-protein, and worsening anemia for the past 3 years who has refused to start treatment for her myeloma. The patient showed iron deficiency anemia in July 2025, and she received Feraheme without significant improvement in her hemoglobin. Last month, her IgG rose to 6756, M-protein to 6.03, and serum free light chain to 314.7. Her blood counts showed her hemoglobin to be 9.6, WBC count 5.7, neutrophil count of 2.88, and platelet count of 210K.

05/20/2026

Dr. James R. Berenson shares insights about taking care of myeloma patients. BerensonCancerCenter.com https://open.substack.com/pub/jamesrberenson/p/clinical-pearls-from-may-18-2026?r=15j6j&utm_campaign=post-expanded-share&utm_medium=web

51 year old white female being treated with the bispecific antibody (BsAb) Lynozyfic which targets the B-cell maturation antigen and T-cells.

04/21/2026

Dr. James R. Berenson answers questions on Empowered Patient.

Dr. Jim Berenson, Founder of the Institute for Myeloma & Bone Cancer Research and the Berenson Cancer Center, describes the Institute's work, which includes maintaining a large biobank of patient samples that support both its own research and that being conducted by external groups. This biobank...

04/20/2026

Extensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. James R. Berenson Institute for Myeloma & Bone Cancer Research (IMBCR) on the Empowered Patient Podcast with Karen Jagoda TRANSCRIPT

Dr. Jim Berenson, Founder of the Institute for Myeloma & Bone Cancer Research and the Berenson Cancer Center, describes the Institute's work, which includes maintaining a large biobank of patient samples that support both its own research and that being conducted by external groups. This biobank...

04/15/2026

Dr. James R. Berenson is available for a second opinion about Myeloma and its related diseases. His myeloma patients are "living the longest in the entire world!" ☎️ 310-623-1222 to schedule. 💪 BerensonCancerCenter.com

04/15/2026

https://www.patientpower.info/video/multiple-myeloma/finding-hope-in-myeloma-inspiring-books-for-patients-and-caregivers
"I have WHAT? Fourth Edition" is available now!This book reveals honest accounts & tips about what it's really like to have myeloma & its related diseases. "YOU have WHAT" shares advice to patients' caregivers. All proceeds support the Institute for Myeloma & Bone Cancer Research (IMBCR) which is a 501(c)3 organization & tax deductible to the extent permitted by law. 's

Author Deborah Berenson shares the inspiration behind her hopeful books for patients with multiple myeloma, Waldenstrom’s, amyloidosis, and MGUS, and the caregivers who support them. Discover real stories, expert insights, and practical tips to help families live better and longer.

04/10/2026

Extensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson - Institute for Myeloma & Bone Cancer Research (IMBCR) on the Empowered Patient Podcast with Karen Jagoda
http://empoweredpatientradio.com/extensive-myeloma-biobank-advancing-research-in-blood-cancer-detection-and-therapies-with-dr-jim-berenson-institute-for-myeloma-bone-cancer-research

Dr. Jim Berenson, Founder of the Institute for Myeloma & Bone Cancer Research and the Berenson Cancer Center, describes the Institute's work, which includes maintaining a large biobank of patient samples that support both its own research and that being conducted by external groups. This biobank...

04/04/2026

Wishing you and yours a Happy Passover and/or Happy Easter.

03/31/2026

THANK YOU IMBCR Supporters! What a great event celebrating you and the Institute's groundbreaking work! Scientists gave guided tours of our state-of-the-art laboratory where they discussed why myeloma patients treated at Berenson Cancer Center are "living the longes in the world!" We had posters to help clarify our current exciting research and also had other projects playing on loop in another area. Guests enjoyed delicious food & drinks, talking with fellow patients, family, friends, & colleagues.

03/04/2026

Dr. James R. Berenson reveals that myeloma patients treated at Berenson Cancer Center have the longest reported survival rate!

In this video, James Berenson, MD, Berenson Cancer Center, West Hollywood, CA, discusses the findings of a recently published retrospective study examining o...